Available Courses
AQDCE | Demystifying the Evolving Science and Potential Role of Incretins in T2D
Estimated Time
0.25 hr
Release Date
Jan 03, 2023
Expiration Date
Jan 02, 2024
AQDCE | Clinical Perspectives on Dual Checkpoint Blockade for mNSCLC
Estimated Time
0.25 hr
Release Date
Dec 28, 2022
Expiration Date
Feb 16, 2024
GVHD-E5 | ECHO Program: Atypical Manifestations of Chronic GVHD
Estimated Time
1.00 hr
Release Date
Dec 08, 2022
Expiration Date
Dec 08, 2023
Demystifying the Evolving Science and Potential Role of Incretins in T2D
Estimated Time
1.25 hr(s)
Release Date
Dec 07, 2022
Expiration Date
Jan 02, 2024
CLL-SLL/MTT Episode 1 - What You MUST Know About the Emerging Standard of Care for 1L Treatment of CLL and SLL
Estimated Time
0.50 hr
Release Date
Dec 01, 2022
Expiration Date
Dec 14, 2023
CLL-SLL/MTT Episode 2 - Moving Towards Fixed-Duration Therapy in CLL and SLL
Estimated Time
0.50 hr
Release Date
Dec 01, 2022
Expiration Date
Dec 14, 2023
CLL-SLL/MTT Episode 3 - Help Your Patients Navigate Risk-benefit Assessment, Choose the Best Therapy for Them, and Mitigate TEAEs
Estimated Time
0.50 hr
Release Date
Dec 01, 2022
Expiration Date
Dec 14, 2023
NSCLC/MTT Episode 3 - Novel Therapeutics: Changing the Treatment Landscape for NSCLC
Estimated Time
0.25 hr
Release Date
Nov 29, 2022
Expiration Date
Nov 28, 2023
NSCLC/MTT Episode 4 - Practical Strategies for Preventing and Mitigating Toxicities of Targeted Therapy
Estimated Time
0.50 hr
Release Date
Nov 29, 2022
Expiration Date
Nov 28, 2023
Making the Right Call: Biomarker Testing and Targeting in NSCLC: Part I: Equitable, Guideline-based Testing for Prognosis and Treatment
Estimated Time
0.50 hr
Release Date
Nov 29, 2022
Expiration Date
Nov 28, 2023
Making the Right Call: Biomarker Testing and Targeting in NSCLC: Part II: Treating Acquired Resistance and Evaluating Next-generation Therapies
Estimated Time
0.25 hr
Release Date
Nov 29, 2022
Expiration Date
Nov 28, 2023
NSCLC/MTT Episode 1 - The Evolution of Biomarker Testing: Revolutionizing Treatment of NSCLC
Estimated Time
0.50 hr
Release Date
Nov 22, 2022
Expiration Date
Nov 28, 2023
NSCLC/MTT Episode 2 - Biomarker Testing: Shaping Personalized Medicine
Estimated Time
0.25 hr
Release Date
Nov 22, 2022
Expiration Date
Nov 28, 2023
AQDCE | EASD: Potential Benefits of Incretins Beyond Glycemic Control in T2D
Estimated Time
0.25 hr
Release Date
Nov 22, 2022
Expiration Date
Oct 09, 2023
GVHD-E4 | ECHO Program: Bronchiolitis Obliterans
Estimated Time
1.00 hr
Release Date
Nov 02, 2022
Expiration Date
Nov 02, 2023
Build Your Own Case Study: A Glimpse at Optimal T2D Management: Enhancing Outcomes with GLP-1 RAs
Estimated Time
1.00 hr
Release Date
Oct 28, 2022
Expiration Date
Oct 27, 2023
Supporting Our Colleagues: Easing the Burden of Referrals for CAR-T in Aggressive B-cell Lymphomas
Estimated Time
1.00 hr
Release Date
Oct 14, 2022
Expiration Date
Oct 29, 2023
Transitioning from Chemoimmunotherapy to More Targeted Approaches in MCL
Estimated Time
1.00 hr
Release Date
Oct 14, 2022
Expiration Date
Oct 30, 2023
Mastering MRD for Prognosis and Treatment in ALL
Estimated Time
1.00 hr
Release Date
Oct 14, 2022
Expiration Date
Oct 29, 2023
Potential Benefits of Incretins Beyond Glycemic Control in T2D
Estimated Time
1.00 hr
Release Date
Oct 14, 2022
Expiration Date